Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EP BiocompositesBOM:543595 76 Pretax Margin % is 18.99% as of Mar. 2026, which is 38% above its 10-year median of 13.73. GuruFocus rates BOM:543595 with a GF Score™ of 76/100 and a GF Value™ of ₹201.91 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,763 Construction companies, EP Biocomposites ranks better than 82.47% on this metric.
EP Biocomposites (BOM:543595) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
EP Biocomposites Pretax Margin % Related Terms
EP Biocomposites Pretax Margin % Historical Data
* Premium members only.
The historical data trend for EP Biocomposites's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543595 vs TT, JCI, CARR: Pretax Margin % Comparison
For the Building Products & Equipment subindustry, EP Biocomposites's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EP Biocomposites Pretax Margin % vs Construction Industry
For the Construction industry and Industrials sector, EP Biocomposites's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where EP Biocomposites's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EP Biocomposites (BOM:543595) has a Pretax Margin % of 18.99% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on EP Biocomposites and its competitors. This is 38% above median its historical median of 13.73. Over the past decade, EP Biocomposites' Pretax Margin % has ranged from 7.59 to 15.75. According to the industry distribution chart, EP Biocomposites ranks #309 out of 1763 companies in the Construction industry, placing it in the top 17.5%.
Is EP Biocomposites' Pretax Margin % too high?
EP Biocomposites' current Pretax Margin % of 18.99% is 38% above median its 10-year median of 13.73. Over the past 10 years, this metric has ranged from a low of 7.59 to a high of 15.75. The Construction industry median Pretax Margin % is 5.47. EP Biocomposites' value of 18.99% is 247.2% above this industry median. Based on the distribution chart, EP Biocomposites ranks #309 out of 1763 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, EP Biocomposites has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' Pretax Margin % compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #309 out of 1763 companies for Pretax Margin %. This places EP Biocomposites in the top 18% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 5.47. EP Biocomposites' value of 18.99% is 247.2% above this benchmark. Historically, EP Biocomposites' own Pretax Margin % has ranged from 7.59 to 15.75 over the past decade. While the company's 10-year median is 13.73 vs. the industry median of 5.47, EP Biocomposites has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Construction company?
The median Pretax Margin % among Construction companies is 5.47, based on 1,763 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EP Biocomposites's current Pretax Margin % of 18.99% is 247.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on EP Biocomposites and its competitors. For the Construction industry, the median Pretax Margin % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EP Biocomposites's current Pretax Margin % is 18.99%, which is 38% above median its own 10-year median of 13.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹201.91, compared to a current price of ₹106.00 — trading 47.5% below its estimated fair value. The current Pretax Margin % is 18.99%, which is 38% above median its 10-year median of 13.73 and 247.2% above the Construction industry median of 5.47. EP Biocomposites' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current Pretax Margin % is 18.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EP Biocomposites (BOM:543595) Overvalued in 2026?
Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued.
The current stock price of ₹106.00 is trading 47.5% below its estimated GF Value™ of ₹201.91.
GuruFocus considers EP Biocomposites to be Significantly Undervalued.
Key valuation signals for BOM:543595:
Pretax Margin %: 18.99% (38% above median its 10-year median of 13.73)
GF Value™: ₹201.91 vs. price of ₹106.00 (47.5% below fair value)
Industry Position: 247.2% above the Construction median (#309 of 1763)
No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
76GF Score
Get the complete analysis for BOM:543595
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543595 has been successfully added to your 
